Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$1.3M
-36.7% from 2023
Prescriptions
56
$23,991.73 per claim
Patients
-
6 prescribers
Total spending, 2024
$1.3M
- per patient
Medicare prescription drug plans paid $1.3M for Zavesca in 2024, for 56 prescriptions and refills to - patients (down 36.7% from 2023). The average cost per claim was $23,991.73.
New York had the highest Medicare cost for Zavesca in 2024: $601K for 16 claims, followed by New Jersey ($514K).
Erica H Parrotta, neurology in Albany, NY, had the highest Medicare cost for Zavesca in 2024: 12 claims costing $399K.
Zavesca is made by Johnson & Johnson (JNJ), listed in the Medicare spending data as Actelion Pharma.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Erica H Parrotta Albany, NY | Neurology | 12 | Under 11 | $399K |
| Hemang U Dave Marmora, NJ | Hematology-Oncology | 14 | Under 11 | $293K |
| Helio F Pedro |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 7 | 78 | - | $2.0M |
| 2023 | 8 | 67 | - | $2.1M |
| 2024 | 6 | 56 | - | $1.3M |
Spending by manufacturer as listed in the spending data
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Internal Medicine |
| 13 |
| Under 11 |
| $220K |
| Manoj Kumar Rio Rancho, NM | Hematology-Oncology | 12 | Under 11 | $211K |
| Manufacturer | Claims | Spending |
|---|---|---|
| Actelion Pharma JNJ | 56 | $1.3M |